The BioIndustry Association (BIA), the Wellcome Sanger Institute and Medicines Discovery Catapult (MDC) have today launched Genomics Nation, showcasing the strength, breadth and opportunity of the UK’s genomics sector for investors, patients and the UK economy.
New analysis shows that biotech shares on the London Stock Exchange continued to out-perform the wider market in the first half of 2021 as international investors were drawn to the UK’s strong science and high-quality companies.
The Life Sciences Sector Vision brings together the collective ambition of the Government and the sector for the UK to be the leading global location for the life sciences businesses to innovate, grow and deliver breakthroughs to patients and the public in all parts of the UK.
New data from the BioIndustry Association (BIA) and Clarivate shows that the UK’s biotech and life sciences sector is on the cusp of a golden age driven by strong demand from global investors for UK innovation, with £1.56bn invested in the last quarter (March 2021 – May 2021). This is the highest total amount ever recorded for a quarter since the trade association began recording this data.
The BIA has today launched a report Public attitudes to Rare Diseases: The case for equal access which presents the findings of a survey commissioned by the BIA on public attitudes towards rare diseases and access to medicine.
The Queen’s Birthday Honours 2021 has been released with several UK biotech and life sciences figures receiving honours for their contributions to the UK’s response to the COVID-19 pandemic.
Those receiving honours include:
Kate Bingham, former Chair of the UK Vaccine Taskforce (VTF), has received a damehood
Ian McCubbin, former Vaccine Manufacturing expert on the VTF, former VP of global supply for GSK and former chair of the BIA’s COVID-19 Vaccine Manufacturing Taskforce, has received a CBE
Annette England (Netty), bioprocessing consultant for the BIA, has received an MBE
Steve Bates OBE, Chief Executive of the BIA said: "The UK has a long legacy in genomic research and the Government is right to build on our global competitive advantage by committing to a series of actions to begin to deliver on the ambitious vision set out in Genome UK. The UK is in a unique position globally to leverage our strong academic base and leadership in major initiatives such as the 100,000 Genomes Project to truly kick-start a world-leading genomics industry.
Steve Bates OBE, Chief Executive of the Bioindustry Association said: “This is not a panacea. Just handing countries governments a recipe book without the ingredients, safeguards, infrastructure, and sizable workforce with the high skills needed to deliver safe and effective vaccines, will not speedily deliver help to all those that need it.
UK biotech companies are on track for a record-breaking year of fundraising according to the latest data released by the UK BioIndustry Association (BIA) and Clarivate. More than £830m in fresh capital was raised in the three months to the end of February, almost topping the £894m raised in the first six months of 2020, which itself was a record-breaking year.